Gain-of-function mutations in CD79B often coexist with MYD88 mutations in extranodal lymphomas, such as primary central nervous system lymphoma (PCNSL) and primary testicular lymphoma (PTL). Here, CD79B is linked to primary central nervous system lymphoma.